Suzhou Junjing Biosciences Co., Ltd.

This study tested an experimental drug called WJ05129 in 26 people with advanced solid tumors that had spread or couldn't be removed. The goal was to find a safe dose and see if the drug could shrink tumors. The study was stopped early, so results are limited.

This study tested a new drug called WJ13405 in 14 people with advanced non-small cell lung cancer that had stopped responding to standard treatments. The goal was to check safety, side effects, and how well the drug worked. The trial was stopped early, so results are limited.